K
Keita Mizuma
Researcher at Hokkaido University
Publications - 6
Citations - 54
Keita Mizuma is an academic researcher from Hokkaido University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications receiving 21 citations.
Papers
More filters
Journal ArticleDOI
The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus Ensures an Ixodid Origin of the Genus Phlebovirus.
Keita Matsuno,Masahiro Kajihara,Ryo Nakao,Naganori Nao,Akina Mori-Kajihara,Mieko Muramatsu,Yongjin Qiu,Shiho Torii,Manabu Igarashi,Nodoka Kasajima,Keita Mizuma,Kentaro Yoshii,Hirofumi Sawa,Chihiro Sugimoto,Ayato Takada,Hideki Ebihara +15 more
TL;DR: The findings suggest that most of the phlebovirus evolution has occurred in hard ticks to generate divergent viruses, which may provide a seminal foundation for understanding the mechanisms underlying the evolution and emergence of pathogenic phleBoviruses, such as Rift Valley fever virus and SFTSV/HRTV.
Journal ArticleDOI
A novel nairovirus associated with acute febrile illness in Hokkaido, Japan.
Fumihiro Kodama,Hiroki Yamaguchi,Eun-Sil Park,Kango Tatemoto,Mariko Sashika,Ryo Nakao,Yurino Terauchi,Keita Mizuma,Yasuko Orba,Hiroaki Kariwa,Katsuro Hagiwara,Katsunori Okazaki,Akiko Goto,Rika Komagome,Masahiro Miyoshi,Takuya Ito,Kimiaki Yamano,Kentaro Yoshii,Chiaki Funaki,Mariko Ishizuka,Asako Shigeno,Yukari Itakura,Lesley Bell-Sakyi,Shunji Edagawa,Atsushi Nagasaka,Yoshihiro Sakoda,Hirofumi Sawa,Ken Maeda,Masayuki Saijo,Keita Matsuno,Keita Matsuno +30 more
TL;DR: Kodama et al. as mentioned in this paper identified a novel orthonairovirus, designated Yezo virus (YEZV), from two patients showing acute febrile illness with thrombocytopenia and leukopenia after tick bite in Hokkaido, Japan, in 2019 and 2020, respectively.
Journal ArticleDOI
Transcranial Doppler for stratification of high-risk morphology of patent foramen ovale in patients with cryptogenic stroke
Saori Chino,Yasuhide Mochizuki,Keita Mizuma,S. Ichikawa,Haruka Miyazaki,Rumi Hachiya,Eiji Toyosaki,Masashi Ota,Hiroto Fukuoka,Toshiko Yamochi,Kenjiro Ono,Toshiro Shinke +11 more
TL;DR: The existence of a large HITS detected by TCD may have a screening advantage in predicting the high-risk morphologies of PFO that can cause paradoxical cerebral embolism.
Journal ArticleDOI
The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle.
TL;DR: In this paper , the pan-ErbB tyrosine kinase inhibitor afatinib was identified as a potent inhibitor of LASV vRNP activity and inhibited multiplication of lymphocytic choriomeningitis virus (LCMV).
Journal ArticleDOI
Reply to ‘patent foramen ovale device closure for patients with stroke and high-risk PFO morphology’
Saori Chino,Yasuhide Mochizuki,Keita Mizuma,S. Ichikawa,Haruka Miyazaki,Rumi Hachiya,Eiji Toyosaki,Hiroto Fukuoka,Kenjiro Ono,Toshiro Shinke +9 more
TL;DR: It is positively hypothesized that ultrasound in combination with TCD and TEE might help identify patients with CS who will significantly benefit from PFO closure, which is beneficial in patients with high-Rope scores with PFO-related cerebral embolism.